UPSC CIVIL SERVICES PRELIMS+ MAINS 2024 GENERAL STUDIES: CURRENT AFFAIRS WEEKLY TEST/UPSC सिविल सेवा प्रारंभिक+मुख्य 2024 सामान्य अध्ययन: समसामयिकी साप्ताहिक टेस्ट (THIS TEST IS AVAILABLE ANYTIME)
WEEK-29 (17-23 DECEMBER 2023)
(NOTE: MARK THE ANSWERS ON YOUR OWN COPY/SHEET)
THIS TEST COMPRISES 40 QUESTIONS FOR PRELIMS & 7 QUESTIONS FOR MAINS (ENG & हिंदी )
(CLICK THE LINK GEVEN BELOW FOR QUESTIONS ANS ANSWERS (ANSWERS AND EXPLANATION IS ONLY FOR PRELIMS. FOR MAINS ONLY TEST MODEL IS AVAILABLE). ONLY SUBSCRIBERS CAN OPEN THESE LINKS. SUBSCRIBERS E-MAIL HAS BEEN ADDED TO THE LINK.)
CLICK HERE FOR QUESTIONS: UPSC PRELIMS CURRENT AFFAIRST TEST WEEK 29 (17-23 DECEMBER 2023)
CLICK HERE FOR ANSWERS: UPSC PRELIMS CURRENT AFFAIRST TEST WEEK 29 (17-23 DECEMBER 2023)
CLICK HERE FOR MAINS MODEL: UPSC MAINS CURRENT ISSUES MODEL TEST WEEK 29 (17-23 DECEMBER 2023)
(NO PDF WILL BE PROVIDED THROUGH EMAIL/कोई पीडीएफ ई-मेल नहीं की जायेगी)
HOW TO SUBSCRIBE: JUST SUBSCRIBE FOR ONE YEAR WEEKLY (52 TESTS) CURRENT AFFAIRS WEEKLY PRELIMS & MAINS TEST IN Rs. 1500. Simply pay Rs. 1500 directly through Paytm/Google Pay/Phone Pe to 9818187354 without sharing any details. After paying through these modes, WhatsApp your e-mail on: 7428811251/9818187354. (TO ACCESS ONE WEEK TEST: PAY RS. 40 TO GIVEN NUMBER) We will ADD YOUR EMAIL IN THIS LINK. CONTACT US: EMAIL: [email protected] // [email protected]. OR WHATSAPP NUMBER: 7428811251/9818187354/GS TIMES UPSC प्रीलिम्स करेंट अफेयर्स साप्ताहिक टेस्ट एक साल (52 टेस्ट) के लिए सब्सक्राइब करें मात्र 1500 रुपये में। आप 1500 रुपये सीधे पेटीएम / Google पे / फोन पे के माध्यम से 9818187354 पर बिना कोई विवरण साझा किए भुगतान करें। (एक सप्ताह यानी इस टेस्ट को एक्सेस करने के लिए: दिए गए नंबर पर 40 रुपये का भुगतान करें) पेमेंट करने के बाद, अपनी ईमेल: 7428811251/9818187354 नंबर पर व्हाट्सएप करें। हमसे संपर्क करें: ईमेल: [email protected] // [email protected]। या व्हाट्सएप नंबर: 7428811251/9818187354
(THIS TEST COMPRISES: CURRENT AFFAIRS BASED QUESTIONS, ANSERS AND EXPLANATION FOR PRELIMS+ONLY TEST QUESTIONS FOR MAINS)
